Not Signed In -
Temozolomide |
Temodar |
Temozolomide Systematic (IUPAC) name 4-methyl-5-oxo- 2,3,4,6,8-pentazabicyclo [4.3.0] nona-2,7,9-triene- 9-carboxamide Identifiers CAS number 85622-93-1 ATC code L01AX03 PubChem 5394 DrugBank APRD00557 Chemical data Formula C6H6N6O2 Mol. weight 194.151 g/mol Pharmacokinetic data Bioavailability ? Protein binding 15% Metabolism spontaneously hydrolized at physiologic pH to the active species, 3-methyl-(triazen-1-yl)imidazole-4-carboxamide (MTIC) and to ...
Wikipedia - [full article]
Temozolomide Clinical Trials
- Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00003464 - Active, not recruiting
Glioblastoma
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
ClinicalTrials.gov Identifier: NCT00389090 - Active, not recruiting
Glioma; Astrocytoma; Oligodendroglioma; Oligoastrocytoma
- Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
ClinicalTrials.gov Identifier: NCT00003304 - Active, not recruiting
Adult Oligodendroglioma
- O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
ClinicalTrials.gov Identifier: NCT00436436 - Recruiting
Brain and Central Nervous System Tumors
- Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain
ClinicalTrials.gov Identifier: NCT00012116 - Active, not recruiting
brain metastases
- Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00091572 - Active, not recruiting
Melanoma
- Bevacizumab, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Previously Treated With Radiation Therapy and Temozolomide
ClinicalTrials.gov Identifier: NCT00535249 - Recruiting
Brain and Central Nervous System Tumors
- Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00262730 - Active, not recruiting
Adult Glioblastoma; Adult Giant Cell Glioblastoma; Adult Gliosarcoma
- Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
ClinicalTrials.gov Identifier: NCT00003731 - Active, not recruiting
Adult Oligodendroglioma; Mixed Gliomas
- Radiation Therapy With or Without Temozolomide in Treating Patients With Non-Small Cell Lung Cancer That is Metastatic to the Brain
ClinicalTrials.gov Identifier: NCT00030836 - Active, not recruiting
brain metastases
- Temozolomide in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors
ClinicalTrials.gov Identifier: NCT00005597 - Active, not recruiting
gastrointestinal stromal tumor
- Temozolomide in Treating Patients With Brain Metastases
ClinicalTrials.gov Identifier: NCT00005954 - Active, not recruiting
brain metastases
- Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
ClinicalTrials.gov Identifier: NCT00200161 - Recruiting
Glioblastoma; Gliomas
- Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
ClinicalTrials.gov Identifier: NCT00005955 - Active, not recruiting
childhood brain tumor; childhood nerve tumor
- Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00006353 - Active, not recruiting
adult glioblastoma multiforme
- Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
ClinicalTrials.gov Identifier: NCT00026494 - Active, not recruiting
brain metastases
- Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00147160 - Recruiting
Glioma
- Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00104988 - Active, not recruiting
Stage IV Melanoma
- Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00004200 - Active, not recruiting
adult glioblastoma multiforme; Quality of Life
- Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
ClinicalTrials.gov Identifier: NCT00006024 - Active, not recruiting
high-grade childhood cerebral astrocytoma
- Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00005815 - Active, not recruiting
intraocular melanoma; Melanoma
- Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00072345 - Active, not recruiting
intraocular melanoma; Melanoma
- Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00544817 - Recruiting
Glioblastoma Multiforme
- Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
ClinicalTrials.gov Identifier: NCT00083096 - Recruiting
adult brain tumor
- Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003747 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
ClinicalTrials.gov Identifier: NCT00033280 - Active, not recruiting
adult anaplastic oligodendroglioma; Mixed Gliomas
- Bevacizumab in Combination with Temozolomide in Patients with Neuroendocrine Tumors
ClinicalTrials.gov Identifier: NCT00137774 - Active, not recruiting
Metastatic Neuroendocrine Tumor; Neuroendocrine Tumor
- IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
ClinicalTrials.gov Identifier: NCT00089427 - Active, not recruiting
Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma
- Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer Involving the Central Nervous System
ClinicalTrials.gov Identifier: NCT00068666 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; brain metastases
- Temozolomide or Dacarbazine in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00101218 - Active, not recruiting
Recurrent Melanoma; Stage IV Melanoma
- Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
ClinicalTrials.gov Identifier: NCT00033709 - Active, not recruiting
adult soft tissue sarcoma; uterine leiomyosarcoma; uterine sarcoma
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00099125 - Active, not recruiting
adult giant cell glioblastoma; adult gliosarcoma; adult glioblastoma
- Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma
ClinicalTrials.gov Identifier: NCT00521482 - Not yet recruiting
Glioblastoma
- Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00016055 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
ClinicalTrials.gov Identifier: NCT00004204 - Active, not recruiting
recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult anaplastic astrocytoma
- Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
ClinicalTrials.gov Identifier: NCT00093353 - Active, not recruiting
Diarrhea; Drug Toxicity; disseminated neuroblastoma; recurrent neuroblastoma
- Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
ClinicalTrials.gov Identifier: NCT00003465 - Active, not recruiting
adult anaplastic oligodendroglioma; recurrent adult brain tumor
- Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
ClinicalTrials.gov Identifier: NCT00004106 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Temozolomide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00080938 - Active, not recruiting
brain metastases; Non-small cell lung cancer
- Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
ClinicalTrials.gov Identifier: NCT00098865 - Active, not recruiting
childhood brain tumor; childhood meningioma; childhood spinal cord tumors; Neuroblastoma
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00047294 - Active, not recruiting
Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00014261 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM
ClinicalTrials.gov Identifier: NCT00508456 - Active, not recruiting
Glioblastoma Multiforme
- Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain
ClinicalTrials.gov Identifier: NCT00020839 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; brain metastases
- Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
ClinicalTrials.gov Identifier: NCT00006025 - Active, not recruiting
adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
- Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
ClinicalTrials.gov Identifier: NCT00003176 - Active, not recruiting
adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas; recurrent adult brain tumor
- Temozolomide in Treating Patients With Recurrent Malignant Glioma
ClinicalTrials.gov Identifier: NCT00004113 - Active, not recruiting
recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma; Quality of Life; ...
- Erlotinib Compared With Temozolomide Or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00086879 - Active, not recruiting
adult glioblastoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
- Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
ClinicalTrials.gov Identifier: NCT00100802 - Active, not recruiting
high-grade childhood cerebral astrocytoma; untreated childhood cerebellar astrocytoma; childhood spinal cord tumors
- Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma
ClinicalTrials.gov Identifier: NCT00109798 - Recruiting
primary central nervous system lymphoma
- Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
ClinicalTrials.gov Identifier: NCT00360945 - Active, not recruiting
Brain and Central Nervous System Tumors
- Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00401180 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma
ClinicalTrials.gov Identifier: NCT00006474 - Active, not recruiting
recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult well-differentiated oligodendroglioma; ...
- Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
ClinicalTrials.gov Identifier: NCT00400816 - Active, not recruiting
Brain and Central Nervous System Tumors
- Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
ClinicalTrials.gov Identifier: NCT00004068 - Active, not recruiting
high-grade childhood cerebral astrocytoma; untreated childhood brain stem glioma; untreated childhood cerebellar astrocytoma; ...
- Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00274833 - Active, not recruiting
Brain and Central Nervous System Tumors
- Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin''s Lymphoma
ClinicalTrials.gov Identifier: NCT00248534 - Recruiting
Primary Central Nervous System Lymphoma
- Temozolomide in Treating Women With Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00005054 - Active, not recruiting
stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
- Prolonged Daily Temozolomide for Low-Grade Glioma
ClinicalTrials.gov Identifier: NCT00165360 - Active, not recruiting
Glioma; Astrocytoma; Oligodendroglioma
- Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
ClinicalTrials.gov Identifier: NCT00383851 - Active, not recruiting
Melanoma
- Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
ClinicalTrials.gov Identifier: NCT00006263 - Active, not recruiting
adult brain stem glioma; adult glioblastoma multiforme; high-grade childhood cerebral astrocytoma; adult anaplastic astrocytoma; ...
- Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov Identifier: NCT00276679 - Active, not recruiting
Neuroblastoma
- Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
ClinicalTrials.gov Identifier: NCT00077207 - Active, not recruiting
untreated childhood cerebellar astrocytoma; untreated childhood visual pathway and hypothalamic glioma; childhood spinal cord tumors; ...
- A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00272415 - Active, not recruiting
Melanoma
- Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
ClinicalTrials.gov Identifier: NCT00098436 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
- Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00003062 - Active, not recruiting
recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
- Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Radiation Therapy or Temozolomide in Treating Patients With Gliomas
ClinicalTrials.gov Identifier: NCT00182819 - Recruiting
Adult Oligodendroglioma; adult diffuse astrocytoma; Mixed Gliomas
- Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin
ClinicalTrials.gov Identifier: NCT00006043 - Active, not recruiting
recurrent testicular cancer; recurrent ovarian germ cell tumor; stage IV ovarian germ cell tumor; stage III testicular cancer
- Temozolomide and Radiation Therapy in Treating Patients With Gliomas
ClinicalTrials.gov Identifier: NCT00114140 - Recruiting
adult diffuse astrocytoma; Adult Oligodendroglioma; Mixed Gliomas
- Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00006877 - Active, not recruiting
stage IV non-small cell lung cancer; Squamous Cell Lung Cancer; recurrent non-small cell lung cancer; Adenocarcinoma of the Lung; Quality of Life; ...
- Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00112502 - Recruiting
adult giant cell glioblastoma; adult gliosarcoma; adult glioblastoma
- Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma
ClinicalTrials.gov Identifier: NCT00283543 - Active, not recruiting
Newly Diagnosed Supratentorial Malignant Glioma
- Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
ClinicalTrials.gov Identifier: NCT00268385 - Recruiting
Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Brain Tumor; Adult Glioblastoma; Mixed Gliomas
- Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
ClinicalTrials.gov Identifier: NCT00404495 - Recruiting
Glioma; Medulloblastoma
- Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00003718 - Active, not recruiting
cellular diagnosis, adult soft tissue sarcoma; cellular diagnosis, uterine sarcoma; Cancer; stage, adult soft tissue sarcoma; ...
- Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide
ClinicalTrials.gov Identifier: NCT00249964 - Recruiting
Lung Diseases; Cancer
- Thalidomide and Temozolomide or CPT-11 in Patients With Gliomas
ClinicalTrials.gov Identifier: NCT00412542 - Recruiting
Glioblastoma Multiforme; Glioma
- Phase 3 Trial of Ticilimumab Versus Either Dacarbazine or Temozolomide in Patients Without Prior Therapy
ClinicalTrials.gov Identifier: NCT00257205 - Active, not recruiting
Melanoma
- Temozolomide in Treating Patients With Low-Grade Glioma
ClinicalTrials.gov Identifier: NCT00313729 - Recruiting
Brain and Central Nervous System Tumors
- Phase II Low-Dose Temozolomide for 2 Weeks on Brain Tumor (Study P04602)
ClinicalTrials.gov Identifier: NCT00424554 - Recruiting
Glioma
- Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas
ClinicalTrials.gov Identifier: NCT00516607 - Recruiting
Brain and Central Nervous System Tumors
- A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients
ClinicalTrials.gov Identifier: NCT00526617 - Recruiting
Solid Tumor; Melanoma
- Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
ClinicalTrials.gov Identifier: NCT00311584 - Recruiting
Brain and Central Nervous System Tumors
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
ClinicalTrials.gov Identifier: NCT00354068 - Recruiting
Brain and Central Nervous System Tumors
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
ClinicalTrials.gov Identifier: NCT00498927 - Recruiting
Brain and Central Nervous System Tumors
- VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
ClinicalTrials.gov Identifier: NCT00516282 - Recruiting
Brain and Central Nervous System Tumors
- Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
ClinicalTrials.gov Identifier: NCT00548938 - Recruiting
Glioblastoma Multiforme; High-Grade Glioma
- Interleukin-13 PE38QQR Immunotoxin and Radiation Therapy With or Without Temozolomide in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Malignant Glioma
ClinicalTrials.gov Identifier: NCT00105014 - Recruiting
adult anaplastic astrocytoma; adult giant cell glioblastoma; adult gliosarcoma; Mixed Gliomas
- Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00005037 - Active, not recruiting
stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
- Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
ClinicalTrials.gov Identifier: NCT00052455 - Recruiting
adult glioblastoma; adult anaplastic astrocytoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma
- Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
ClinicalTrials.gov Identifier: NCT00304031 - Recruiting
Brain and Central Nervous System Tumors
- Valproic Acid, Temozolomide, and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00313664 - Recruiting
Brain and Central Nervous System Tumors
- VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
ClinicalTrials.gov Identifier: NCT00369590 - Recruiting
Brain and Central Nervous System Tumors
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
ClinicalTrials.gov Identifier: NCT00492687 - Recruiting
Brain and Central Nervous System Tumors
- Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma
ClinicalTrials.gov Identifier: NCT00575887 - Recruiting
Glioblastoma; Astrocytoma; Oligodendroglioma; Brain Tumor, Recurrent
- Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00482677 - Recruiting
Brain and Central Nervous System Tumors
- Hydroxychloroquine, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00486603 - Recruiting
Brain and Central Nervous System Tumors
- O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
ClinicalTrials.gov Identifier: NCT00275002 - Recruiting
Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Brain Tumor; High-Grade Childhood Cerebral Astrocytoma; ...
Resources
- Temodar (Drug Digest)
- Temodar Consumer Information (U.S. Food and Drug Administration)
email this page
print this page
bookmark this page
feedback on this page
